Protalix BioTherapeutics Inc (PLX)
1.14
-0.02
(-1.72%)
USD |
NYAM |
May 03, 16:00
1.145
0.00 (0.00%)
After-Hours: 20:00
Protalix BioTherapeutics Cash from Investing (Quarterly): -0.342M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.342M |
| September 30, 2023 | -20.88M |
| June 30, 2023 | -0.222M |
| March 31, 2023 | 4.732M |
| December 31, 2022 | 4.953M |
| September 30, 2022 | 5.912M |
| June 30, 2022 | 0.357M |
| March 31, 2022 | -16.26M |
| December 31, 2021 | 37.44M |
| September 30, 2021 | 4.629M |
| June 30, 2021 | 7.54M |
| March 31, 2021 | -30.68M |
| December 31, 2020 | 7.592M |
| September 30, 2020 | 7.803M |
| June 30, 2020 | -0.268M |
| March 31, 2020 | -35.08M |
| December 31, 2019 | 0.029M |
| September 30, 2019 | -0.446M |
| June 30, 2019 | -0.095M |
| March 31, 2019 | -0.371M |
| December 31, 2018 | 0.084M |
| September 30, 2018 | -0.228M |
| June 30, 2018 | -0.119M |
| March 31, 2018 | -0.328M |
| December 31, 2017 | -0.034M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.116M |
| June 30, 2017 | -0.686M |
| March 31, 2017 | -0.283M |
| December 31, 2016 | -0.242M |
| September 30, 2016 | -0.066M |
| June 30, 2016 | -0.366M |
| March 31, 2016 | -0.293M |
| December 31, 2015 | 39.90M |
| September 30, 2015 | -0.169M |
| June 30, 2015 | -0.248M |
| March 31, 2015 | -0.099M |
| December 31, 2014 | -0.169M |
| September 30, 2014 | -0.267M |
| June 30, 2014 | -0.195M |
| March 31, 2014 | -0.37M |
| December 31, 2013 | -0.271M |
| September 30, 2013 | -0.419M |
| June 30, 2013 | -0.723M |
| March 31, 2013 | -0.689M |
| December 31, 2012 | -0.376M |
| September 30, 2012 | -0.819M |
| June 30, 2012 | -0.239M |
| March 31, 2012 | -0.852M |
| December 31, 2011 | -0.747M |
| September 30, 2011 | -1.028M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-35.08M
Minimum
Mar 2020
37.44M
Maximum
Dec 2021
-1.226M
Average
0.029M
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
| Agenus Inc | 2.824M |
| InfuSystems Holdings Inc | -1.044M |
| AIM ImmunoTech Inc | -0.214M |
| Perspective Therapeutics Inc | -0.089M |
| Armata Pharmaceuticals Inc | -2.39M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.595M |
| Free Cash Flow | -2.467M |
| Free Cash Flow Per Share (Quarterly) | 0.0386 |
| Free Cash Flow to Equity (Quarterly) | 3.286M |
| Free Cash Flow to Firm (Quarterly) | 4.108M |
| Free Cash Flow Yield | -2.78% |